Integris Baptist Medical Center

Oklahoma City, Oklahoma 73162

5 studies enrolling now · 82 studies all time

What they study most

Advanced Refractory Left Ventricular Heart Failure, Adverse Effect of MRI on an Implanted Pacemaker, Adverse Effect of MRI on an Implanted Pacemaker Lead, Angina (stable), Antibody-mediated Rejection, Aortic Stenosis, Aortic Valve Disease, Aortic Valve Insufficiency, Aortic Valve Replacement, Aortic Valve Stenosis, Atherosclerosis, Atrial Fibrillation

Studies at this site

• Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
• Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System — Recruiting now
• Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial — Recruiting now
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure — Recruiting now
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
• Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
• Surveillance HeartCare® Outcomes Registry — Running, not enrolling
• The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System — Completed
• MitraClip REPAIR MR Study — Running, not enrolling
• Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Running, not enrolling
• ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement — Running, not enrolling
• Molecular Assessment and Profiling of Liver Transplant Recipients — Running, not enrolling
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
• A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension — Running, not enrolling
• Abbott Ventricular Tachycardia PAS — Running, not enrolling
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR — Running, not enrolling
• Optisure Lead Post Approval Study — Stopped early
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• MitraClip EXPAND G4 Study — Running, not enrolling
• The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker — Completed
• Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. — Completed
• The ARIES HeartMate 3 Pump IDE Study — Completed
• Benefits of Microcor in Ambulatory Decompensated Heart Failure — Completed
• CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery — Stopped early
• Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling — Completed
• Performance of the Acoustic Based CADScor System in Coronary Artery Disease — Starting soon
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia — Completed
• WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement — Completed
• Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH — Stopped early
• Identifying and Facilitating Ventricular Recovery on Mechanical Support — Completed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension — Completed
• Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry — Status unconfirmed
• Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS — Completed
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE — Stopped early
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin — Completed
• Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 — Completed
• Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH — Stopped early
• LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices — Completed
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE — Completed
• SHIELD II Clinical Investigation — Stopped early
• Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy — Completed
• Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy — Completed
• MOMENTUM 3 Continued Access Protocol — Completed
• MOMENTUM 3 IDE Clinical Study Protocol — Completed
• Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation — Completed
• Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant — Completed